What is Dynavax Technologies Corporation?
Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally. The company offers HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in adults aged 18 years and older; and CpG 1018, the adjuvant used in HEPLISAV-B. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 1.82B.
A short list of Drug Manufacturers - Specialty & Generic names that are close enough in size to make side-by-side comparison useful.